Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 08-Apr-22 4:21 PM View:  | Keros Therapeutics, Inc. (KROS) | 06-Apr-22 | Option Exercise | 1,728 | $16.00 | $27,648.00 | 100% 0 to 1.73K | |
| 08-Apr-22 4:21 PM View: | Keros Therapeutics, Inc. (KROS) | 06-Apr-22 | Planned Option Sale | 1,728 | $65.00 | $112,320.00 | (100%) 1.73K to 0 | |
| 05-Apr-22 4:31 PM View: | Keros Therapeutics, Inc. (KROS) | 01-Apr-22 | Option Exercise | 864 | $16.00 | $13,824.00 | 100% 0 to 0.86K | |
| 05-Apr-22 4:31 PM View: | Keros Therapeutics, Inc. (KROS) | 01-Apr-22 | Planned Option Sale | 864 | $57.49 | $49,675.10 | (100%) 0.86K to 0 | |
| 04-Apr-18 4:41 PM View: | Acceleron Pharma Inc (XLRN) | 03-Apr-18 | Market Sale (Planned) | 3,500 | $38.40 | $134,395.00 | (12%) 29.36K to 25.86K | (368%) |
| 05-Mar-18 5:16 PM View: | Acceleron Pharma Inc (XLRN) | 01-Mar-18 | Grant | 4,063 | -- | -- | 16% 24.7K to 28.76K | |
| 17-Jan-18 5:14 PM View: | Acceleron Pharma Inc (XLRN) | 12-Jan-18 | Option Exercise | 11,000 | $24.11 | $265,210.00 | 45% 24.7K to 35.7K | |
| 17-Jan-18 5:14 PM View: | Acceleron Pharma Inc (XLRN) | 12-Jan-18 | Market Option Sale (Planned) | 11,000 | $45.00 | $495,000.00 | (31%) 35.7K to 24.7K | (299%) |
| 04-Jan-18 7:05 PM View: | Acceleron Pharma Inc (XLRN) | 03-Jan-18 | Market Sale (Planned) | 833 | $42.45 | $35,360.90 | (3%) 25.53K to 24.7K | (323%) |
| 04-Jan-18 7:05 PM View: | Acceleron Pharma Inc (XLRN) | 02-Jan-18 | Market Sale (Planned) | 1,433 | $42.41 | $60,773.50 | (5%) 26.97K to 25.53K | (324%) |
| 14-Sep-17 5:04 PM View: | Acceleron Pharma Inc (XLRN) | 12-Sep-17 | Market Sale (Planned) | 14,000 | $38.41 | $537,786.00 | (34%) 40.97K to 26.97K | (368%) |